Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 1033.6× sales vs its 125.4× historical median P/S.
Fair value ≈ $2.61 · price $21.55 today
Overvalued · 725% above
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
IVDA $100 potential, it might sound crazy but look into it. it is developing advanced AI-powered drones that scan for weapons, track movement, and provide real-time threat detection.
Imagine that in every school, hospital, or stadium.
Right now, it’s still under $1.00. But that won’t last....
$GROM $FUSN $ALT $VIRI
@Impatient_Investor
Look at my past posts on $RGLS and $FUSN. No daydreaming there, only hard profitable reality and that certainly beats earning 20$ an hour bashing promising biotech companies like you do!
I’ve been doing this for 20 years and done very well so far. You?
@Impatient_Investor
Recently:
$RGLS a few weeks ago. (X7 with another x7 CVR)
$FUSN last year (x10 with a x1 CVR)
Both were extraordinarily lucrative. And look at my previous post (before the buyouts!). They more than make up for the lemons.
$DTIL is in my opinion another one that will potentially go up x10
$VRDN Went Down to $12s, then Ran Up to $25s (42%+ GAIN, 9+ Mths)
$SLDB Ran to $15 (100% Profit, 2Mths)
$FUSN BO at $21+ (less then 2Mths, $10 per share profit)
Perceptive Advisors, that they are👈👀🦏
$RADX
New Radiopharm company on Nasdaq backed by Lantheus and in collaborations with MD Anderson- $36 million market cap. Lantheus just bought shares at 150% premium.
$RYZB $FUSN
@salmonbrain Sorry I misread your message. In 2024, they went 3 for 5. The mean return was 75.2% while the median return was 85.8%. The 2024 picks included $FUSN, $NAMS, $KRYS, $IONS and $CABA. The respective returns were 292.5%, 104.9%, 85.8%, -30.8% and -76.2%.
$FUSN I’m going to wait a few years. Need to really educate myself here. Hope they have plenty of success with drug. I guess Canada Pension Plan has money to burn. I don’t. I’m just trying to pay my monthly bills. Delusional Kenny
$ICCM I've only ever held stock in 1 company that went through the roof overnight and that was Fusion Pharmaceuticals $FUSN .. That was a great day. Hopefully this will do the same.
$MNPR
Monopar’s MNPR101-Lu mechanism of action is just like Pluvicto (Top Novartis Radiopharm Drug) and same lutetium-177 warhead. Could take Monopar from $15 million market cap to $1.5 billion. Company barely spends any money and float is small. Diamond in the rough.
https://m.youtube.com/watch?v=a4e0NsEbk_U
$FUSN $RYZB $CATX
